IFNG and myasthenia gravis: As shown in Figure 4A, we observed a significant increase in the frequency of CD3+ IFN-γ+ T cells in MDSC depleted PBMCs compared with undepleted PBMCs from both HCs (n = 5, p = 0.0099, Figure 4B) and from patients with MG after immunotherapy (n = 6, p = 0.033, Figure 4D).